Exchange Traded Concepts’s TG Therapeutics TGTX Stock Holding History

Exchange Traded Concepts’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63M	Sell	29,701 -492	-2%	-$20.1K	0.01%	780
2026 Q1	$1M	Buy	30,193 +5,844	+24%	+$174K	0.01%	806
2025 Q4	$726K	Sell	24,349 -714	-3%	-$23.3K	0.01%	929
2025 Q3	$905K	Buy	+25,063	New	+$826K	0.01%	809
2023 Q4	–	Sell	-2,174	Closed	-$18.2K	–	1390
2023 Q3	$18.2K	Buy	+2,174	New	+$30.3K	﹤0.01%	1132

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Exchange Traded Concepts's TGTX Position: Q2 2026 in Review

Exchange Traded Concepts reduced its TG Therapeutics (TGTX) stake by 1.6% in Q2 2026, selling an estimated $20.1K and leaving 29,701 shares worth $1.63M. The position accounts for 0.01% of the portfolio, ranked #780.

Exchange Traded Concepts first reported a position in TGTX in Q3 2023 and has held it in 5 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Exchange Traded Concepts held 29,701 shares of TG Therapeutics worth $1.63M as of Q2 2026.
Exchange Traded Concepts sold 492 TG Therapeutics shares in Q2 2026, an estimated $20.1K.
TG Therapeutics made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #780 holding.
Exchange Traded Concepts first reported a position in TG Therapeutics in Q3 2023 and has held it in 5 quarters since.
431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.